Caplin Point Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled to be held on November 09, 2016, to consider, approve and take on record the Un-audited Financial Results for the quarter/half year ended September 30, 2016. Accordingly, the Trading Window for dealing in the equity shares of the Company will remain closed for Promoters, Directors, other Connected Persons and Employees of the Company from October 19, 2016 to November 11, 2016 as per the Company’s Code of Conduct to regulate, monitor and report trading by insiders adopted by the Board pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015.
The above information is a part of company’s filings submitted to BSE.
